Faculty of Pharmaceutical Sciences, School of Health Sciences, University of Iceland, Hofsvallagata 53, IS-107 Reykjavík, Iceland.
Department of Biomedical Science, Faculty of Medicine, University of Iceland, Stapi, Hringbraut 31, 101 Reykjavík, Iceland.
Carbohydr Polym. 2015;127:407-17. doi: 10.1016/j.carbpol.2015.03.061. Epub 2015 Mar 30.
A new synthetic approach employing two types of protecting groups, tertiarybutyldimethylsilyl (TBDMS) and tertiarybutyloxycarbonyl (Boc) was developed to obtain a series of guanidinylated chitosan derivatives. The synthesis was carried out in organic solvents which allowed quantitative reaction, a good control on the degree of substitution, and 100% substitution of the chitosan amino groups. Similar derivatives carrying the trimethylammonium group were also synthesized as reference compounds. All the derivatives were characterized using (1)H and COSY NMR and IR spectroscopy. The antibacterial effect against clinically relevant strains of S. aureus and E. coli was found to increase with increase in the degree of substitution and decrease in the spacer length of the derivatives in both the series. An optimum activity could be obtained at a degree of substitution above 0.5 for most derivatives. The trimethylammonium derivatives showed slightly higher activity than the corresponding guanidinium derivatives but a similar structure-activity relationship was obtained.
采用两种保护基,叔丁基二甲基甲硅烷基(TBDMS)和叔丁氧羰基(Boc),开发了一种新的合成方法,以获得一系列胍基化壳聚糖衍生物。该合成在有机溶剂中进行,允许定量反应,对取代度有很好的控制,并且壳聚糖氨基的取代度达到 100%。还合成了带有三甲铵基团的类似衍生物作为参考化合物。所有衍生物均使用(1)H 和 COSY NMR 和 IR 光谱进行表征。发现两种系列的衍生物的取代度增加和间隔基长度减小,对临床相关金黄色葡萄球菌和大肠杆菌菌株的抗菌作用增强。大多数衍生物在取代度大于 0.5 时可以获得最佳活性。三甲基铵衍生物的活性略高于相应的胍基衍生物,但得到了相似的构效关系。